Literature DB >> 9192019

Murine model of rotavirus infection.

N Feng1, M A Franco, H B Greenberg.   

Abstract

The murine model of homologous rotavirus infection has been used to study the determinants of protection. The local IgA immune response appears to be the critical factor in generating protective immunity after natural infection. A series of knockout mice were used to evaluate the contribution of T cells and B cells to immunity and resolution from primary infection. Both arms of immune system played a role in the resolution of primary infection but antibody was much more important for prevention of reinfection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192019     DOI: 10.1007/978-1-4899-1828-4_35

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Authors:  Benyue Zhang; Benoit Chassaing; Zhenda Shi; Robin Uchiyama; Zhan Zhang; Timothy L Denning; Sue E Crawford; Andrea J Pruijssers; Jason A Iskarpatyoti; Mary K Estes; Terence S Dermody; Wenjun Ouyang; Ifor R Williams; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Science       Date:  2014-11-14       Impact factor: 47.728

2.  Rotavirus infection is not associated with small intestinal fluid secretion in the adult mouse.

Authors:  Shirin Kordasti; Claudia Istrate; Mahanez Banasaz; Martin Rottenberg; Henrik Sjövall; Ove Lundgren; Lennart Svensson
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.

Authors:  Shannon M Mumphrey; Harish Changotra; Tara N Moore; Ellen R Heimann-Nichols; Christiane E Wobus; Michael J Reilly; Mana Moghadamfalahi; Deepti Shukla; Stephanie M Karst
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.

Authors:  Yanhua Song; Ningguo Feng; Liliana Sanchez-Tacuba; Linda L Yasukawa; Lili Ren; Robert H Silverman; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model.

Authors:  Kelly L Warfield; Sarah E Blutt; Sue E Crawford; Gagandeep Kang; Margaret E Conner
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

6.  Use of fluoroscopy to study in vivo motility in mouse pups.

Authors:  Kent Williams; Tatsuki Koyama; Daryl Schulz; Grzegorz L Kaluza; Robia G Pautler; Norman Weisbrodt; Margaret E Conner
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-06       Impact factor: 2.839

7.  Lymphotoxin alpha-deficient mice clear persistent rotavirus infection after local generation of mucosal IgA.

Authors:  Uri Lopatin; Sarah E Blutt; Margaret E Conner; Brian L Kelsall
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.

Authors:  Robin Uchiyama; Benoit Chassaing; Benyue Zhang; Andrew T Gewirtz
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

9.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

10.  Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.

Authors:  Lorena Garaicoechea; Aurelien Olichon; Gisela Marcoppido; Andrés Wigdorovitz; Marina Mozgovoj; Linda Saif; Thomas Surrey; Viviana Parreño
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.